Please login to the form below

Magic of Lucid targets rare and specialist diseases

Lucid Group, the award-winning global medical communications company with offices in London, Buckinghamshire, Macclesfield and New York, has announced the launch of a new agency specialising in rare and specialist diseases.

Vivid MedComms Limited, based in Loudwater Buckinghamshire, will be headed by Alison Cantle (Managing Director), who has over 20 years’ medical communications experience.

This move mirrors an industry-wide shift towards focusing on rare and specialist diseases, with revenues from orphan drugs outpacing sales of mainstream drugs for the last decade, a trend that’s expected to continue for the next 30 years. According to the Orphan Drug Report (2015), sales of orphan drugs will account for 20% of all prescription drug sales by 2020.

Alison commented, “Our business in rare diseases has increased threefold over the last year. Making the decision to create a new stand-alone company focused on this area is an obvious choice. We have developed a dedicated and talented team of account handlers and medical writers brimming with specific skills and experience related to developing excellent comms programmes in rare diseases. The team are excited by the challenge and looking forward to transforming the lives of both clients and teams in this space.”  

If you would like to discuss medical education support from the Vivid team, please contact:

M: 07780 455605

10th November 2017



Company Details

Lucid Group Communications Limited

+44 01494 755712

Contact Website

Burleighfield House
London Road
HP10 9RF

Latest content on this profile

Measures for measures
Why pharma’s marketing metrics must close the loop
Lucid Group Communications Limited
My adventure into the world of Medcomms and Lucid’s Futures Academy

Lucid Group Communications Limited
Graduation day is celebrated by Lucid’s third Futures Academy cohort

Lucid Group Communications Limited
Bluedog Launch Celebrations
Teams from all companies within the Lucid Group and Bluedog gathered to celebrate both the launch of this new partnership and Lucid Group’s twelve-year anniversary.  2019 is set to be a transformative year for Lucid Group, which, with the support of its private equity partner LDC, has big ambitions to build broader capability and reach by bringing even more magic to the mix through future acquisitions.
Lucid Group Communications Limited
Lighthouse Medical Communications US appoints Lisa Druce as its new Managing Partner

Lucid Group Communications Limited
Lucid Group brings creative and digital magic to the mix with the acquisition of Bluedog

Lucid Group Communications Limited